Literature DB >> 19378224

Influence of smoking cessation on airway T lymphocyte subsets in COPD.

Ester Roos-Engstrand1, Barbro Ekstrand-Hammarström, Jamshid Pourazar, Annelie F Behndig, Anders Bucht, Anders Blomberg.   

Abstract

The mechanisms behind airway inflammation in chronic obstructive pulmonary disease (COPD) are still not well understood. Here we investigated lymphocyte subtypes in bronchoalveolar lavage fluid, likely to be involved in the pathogenesis of COPD, as well as exploring the effect of smoking cessation. Differential cell counts and T cell subsets were determined in BAL fluid from nineteen individuals with stable COPD (seven smokers, twelve ex-smokers) compared to twelve age-matched never-smokers and thirteen smoking-matched smokers with normal lung function. COPD-patients had higher percentages of airway CD8(+) T cells compared to never-smokers. An increased population of CD4(+) T cells expressed high levels of CD25 in smokers and COPD patients compared to never-smokers, suggesting the presence of regulatory T cells. As the T cell populations in smokers with normal lung function and COPD-patients were similar, the impact of current smoking in COPD was addressed in a subgroup analysis. Activation of CD8(+) T cells was found regardless of smoking habits. In contrast, the enhanced expression of gamma/delta T cells, was mainly associated with current smoking, whilst the increase in T regulatory cells appeared related to both smoking and COPD. Regardless of smoking habits, CD8(+) T cell activation was found in COPD, supporting the contention that this T cell subset may play a role in the pathogenesis of COPD. As CD8(+) T cells coexist with immunoregulatory CD4(+) T cells in airways of COPD patients, it is likely that both cytotoxic T-cell responses and immunosuppressive mechanisms may be of importance in COPD pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19378224     DOI: 10.1080/15412550902755358

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  20 in total

1.  Impaired CTLA-4 responses in COPD are associated with systemic inflammation.

Authors:  Dino B A Tan; Sonia Fernandez; Patricia Price; Martyn A French; Philip J Thompson; Yuben P Moodley
Journal:  Cell Mol Immunol       Date:  2014-03-24       Impact factor: 11.530

2.  Maintained smoking cessation for 6 months equilibrates the percentage of sputum CD8+ lymphocyte cells with that of nonsmokers.

Authors:  Izolde Bouloukaki; Maria Tsoumakidou; Constantine I Vardavas; Ioanna Mitrouska; Eleni Koutala; Nikolaos M Siafakas; Sophia E Schiza; Nikos Tzanakis
Journal:  Mediators Inflamm       Date:  2010-02-23       Impact factor: 4.711

3.  Cytotoxic T cells expressing the co-stimulatory receptor NKG2 D are increased in cigarette smoking and COPD.

Authors:  Ester Roos-Engstrand; Jamshid Pourazar; Annelie F Behndig; Anders Blomberg; Anders Bucht
Journal:  Respir Res       Date:  2010-09-24

4.  Live attenuated influenza virus (LAIV) induces different mucosal T cell function in nonsmokers and smokers.

Authors:  Katherine M Horvath; Luisa E Brighton; Margaret Herbst; Terry L Noah; Ilona Jaspers
Journal:  Clin Immunol       Date:  2012-01-06       Impact factor: 3.969

5.  Expansion of CD4+CD25+ helper T cells without regulatory function in smoking and COPD.

Authors:  Ester Roos-Engstrand; Jamshid Pourazar; Annelie F Behndig; Anders Bucht; Anders Blomberg
Journal:  Respir Res       Date:  2011-06-08

6.  Cell recovery in bronchoalveolar lavage fluid in smokers is dependent on cumulative smoking history.

Authors:  Reza Karimi; Göran Tornling; Johan Grunewald; Anders Eklund; C Magnus Sköld
Journal:  PLoS One       Date:  2012-03-29       Impact factor: 3.240

7.  Basal gene expression by lung CD4+ T cells in chronic obstructive pulmonary disease identifies independent molecular correlates of airflow obstruction and emphysema extent.

Authors:  Christine M Freeman; Alexandra L McCubbrey; Sean Crudgington; Joshua Nelson; Fernando J Martinez; MeiLan K Han; George R Washko; Stephen W Chensue; Douglas A Arenberg; Catherine A Meldrum; Lisa McCloskey; Jeffrey L Curtis
Journal:  PLoS One       Date:  2014-05-07       Impact factor: 3.240

8.  Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis.

Authors:  Mingming Deng; Yan Yin; Qin Zhang; Xiaoming Zhou; Gang Hou
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

9.  Differential activation of killer cells in the circulation and the lung: a study of current smoking status and chronic obstructive pulmonary disease (COPD).

Authors:  Jia Wang; Richard A Urbanowicz; Patrick J Tighe; Ian Todd; Jonathan M Corne; Lucy C Fairclough
Journal:  PLoS One       Date:  2013-03-11       Impact factor: 3.240

Review 10.  The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease.

Authors:  Fariz Nurwidya; Triya Damayanti; Faisal Yunus
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-12-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.